BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36098508)

  • 1. Development of PLGA Nanoparticles with a Glycosylated Myelin Oligodendrocyte Glycoprotein Epitope (MOG
    Triantafyllakou I; Clemente N; Khetavat RK; Dianzani U; Tselios T
    Mol Pharm; 2022 Nov; 19(11):3795-3805. PubMed ID: 36098508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design and synthesis of altered peptide ligands based on human myelin oligodendrocyte glycoprotein 35-55 epitope: inhibition of chronic experimental autoimmune encephalomyelitis in mice.
    Tselios T; Aggelidakis M; Tapeinou A; Tseveleki V; Kanistras I; Gatos D; Matsoukas J
    Molecules; 2014 Nov; 19(11):17968-84. PubMed ID: 25375337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Injection of Myelin Oligodendrocyte Glycoprotein-coated PLGA Microparticles Have Tolerogenic Effects in Experimental Autoimmune Encephalomyelitis.
    Gholamzad M; Ebtekar M; Shafiee Ardestani M
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):271-281. PubMed ID: 28732440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.
    Cappellano G; Woldetsadik AD; Orilieri E; Shivakumar Y; Rizzi M; Carniato F; Gigliotti CL; Boggio E; Clemente N; Comi C; Dianzani C; Boldorini R; Chiocchetti A; Renò F; Dianzani U
    Vaccine; 2014 Sep; 32(43):5681-9. PubMed ID: 25149432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
    Derdelinckx J; Mansilla MJ; De Laere M; Lee WP; Navarro-Barriuso J; Wens I; Nkansah I; Daans J; De Reu H; Jolanta Keliris A; Van Audekerke J; Vanreusel V; Pieters Z; Van der Linden A; Verhoye M; Molenberghs G; Hens N; Goossens H; Willekens B; Cras P; Ponsaerts P; Berneman ZN; Martínez-Cáceres EM; Cools N
    J Neuroinflammation; 2019 Aug; 16(1):167. PubMed ID: 31416452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive ELISA for the identification of 35-55 myelin oligodendrocyte glycoprotein immunodominant epitope conjugated with mannan.
    Gkika A; Androutsou ME; Aletras AJ; Tselios T
    J Pept Sci; 2023 Oct; 29(10):e3493. PubMed ID: 37041122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct modulation of myelin-autoreactive CD4
    Pei W; Wan X; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
    Int J Nanomedicine; 2018; 13():3731-3750. PubMed ID: 29983566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis.
    Androutsou ME; Nteli A; Gkika A; Avloniti M; Dagkonaki A; Probert L; Tselios T; Golič Grdadolnik S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration methods and dosage of poly(lactic acid)-glycol intervention to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalitis mice.
    Wright AE; Nishiyama S; Han P; Kong P; Levy M
    BMC Neurosci; 2024 Mar; 25(1):16. PubMed ID: 38468222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual peptide nanoparticle platform for enhanced antigen-specific immune tolerance for the treatment of experimental autoimmune encephalomyelitis.
    Wang H; Shang J; He Z; Zheng M; Jia H; Zhang Y; Yang W; Gao X; Gao F
    Biomater Sci; 2022 Jul; 10(14):3878-3891. PubMed ID: 35686489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis.
    Gholamzad M; Baharlooi H; Shafiee Ardestani M; Seyedkhan Z; Azimi M
    Adv Pharm Bull; 2021 May; 11(3):505-513. PubMed ID: 34513625
    [No Abstract]   [Full Text] [Related]  

  • 13. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
    Pacini G; Ieronymaki M; Nuti F; Sabatino G; Larregola M; Aharoni R; Papini AM; Rovero P
    J Pept Sci; 2016 Jan; 22(1):52-8. PubMed ID: 26663200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Delarasse C; Smith P; Baker D; Amor S
    Immunology; 2013 Dec; 140(4):456-64. PubMed ID: 23876060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
    Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
    J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
    Buerth C; Mausberg AK; Heininger MK; Hartung HP; Kieseier BC; Ernst JF
    PLoS One; 2016; 11(5):e0155082. PubMed ID: 27159446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis.
    Wang X; Zhang J; Baylink DJ; Li CH; Watts DM; Xu Y; Qin X; Walter MH; Tang X
    Sci Rep; 2016 Oct; 6():36064. PubMed ID: 27796368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
    Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
    Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice.
    Bittner S; Afzali AM; Wiendl H; Meuth SG
    J Vis Exp; 2014 Apr; (86):. PubMed ID: 24797125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.